Table 3 Comparison of the predictive accuracy of the prognostic models.
From: Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma
Models | Recurrence free survival | Overall survival | ||||
|---|---|---|---|---|---|---|
C-index (95%CI) | Coefficient (95%CI) | P-value | C-index (95%CI) | Coefficient (95%CI) | P-value | |
Tumoral Dectin-1 | 0.643 (0.587–0.700) | — | 0.638 (0.585 –0.691) | — | ||
TNM | 0.658 (0.600–0.716) | — | 0.702 (0.648–0.757) | — | ||
TNM + Tumoral Dectin-1 | 0.708 (0.650–0.767) | 0.050 (0.012–0.089) | 0.001† | 0.747 (0.694–0.800) | 0.045 (0.013–0.078) | 0.006† |
SSIGN | 0.718 (0.665–0.772) | — | 0.740 (0.692–0.787) | — | ||
SSIGN + Tumoral Dectin-1 | 0.762 (0.708–0.815) | 0.044 (0.008–0.080) | 0.017† | 0.772 (0.723–0.821) | 0.032 (−0.006–0.071) | 0.093† |
UISS | 0.713 (0.662–0.764) | — | 0.723 (0.670–0.776) | — | ||
UISS + Tumoral Dectin-1 | 0.760 (0.709–0.811) | 0.047 (0.023–0.072) | 0.010† | 0.763 (0.713–0.814) | 0.040 (0.001–0.080) | 0.050† |
Nomogram | 0.796 (0.747–0.846) | — | 0.812 (0.769–0.856) | — | ||
Nomogram vs SSIGN | ||||||
in all patients | — | 0.086 (0.435–0.129) | <0.001‡ | — | 0.072 (0.036–0.110) | <0.001‡ |
in SSIGN low/intermediate groups | — | 0.097 (0.049–0.146) | <0.001‡ | — | 0.099 (0.053–0.146) | <0.001‡ |
Nomogram vs UISS | ||||||
in all patients | — | 0.082 (0.045–0.119) | <0.001‡ | — | 0.089 (0.043–0.135) | <0.001‡ |
in UISS low/intermediate groups | — | 0.095 (0.069–0.130) | <0.001‡ | — | 0.092 (0.052–0.133) | <0.001‡ |
